Glen Pyle: Association Between Premature Menopause and Coronary Heart Disease Risk
Glen Pyle, Professor, Member of Women’s Health Research Institute (WHRI) and of IMPART, shared a post on LinkedIn about a recent article by Priya M. Freaney et al. published in JAMA Cardiology:
“Menopause increases women’s cardiovascular disease risk and women who experience menopause before age 40 have an even higher risk.
A new study in JAMA Cardiology investigated the connection between premature menopause and coronary heart disease, and found Black women were threefold more likely than White women to enter menopause before age 40 (15.5% vs 4.8%).
The risk of coronary heart disease in these women was 40% higher than women who entered menopause after age 40, regardless of racial background.
Earlier studies have demonstrated a link between early (<45 years of age) and premature (<40 years of age) menopause with coronary heart disease within 7 years of menopause.
This study looked at a significantly longer window of risk (~30 years) and shows that the elevated risk persists.
While menopause is typically seen as a ‘reproductive’ issue best dealt with by gynecology professionals, this study by Priya M. Freaney and colleagues underscores the need for women, family physicians, and cardiologists to consider reproductive history in assessing cardiovascular disease risk.
Clear communication about patient history, risk factors, and strategies to mitigate cardiovascular risks are critical for ensuring a long and healthy life for women.”
Title: Premature Menopause and Lifetime Risk of Coronary Heart Disease
Authors: Priya M. Freaney, Hongyan Ning, Mercedes Carnethon, John T. Wilkins, Norrina B. Allen, Donald M. Lloyd-Jones, Sadiya S. Khan
Read the Full Article on JAMA Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 19, 2026, 15:14Georgiana Toma: Addressing Iron Deficiency Without Anemia
-
Mar 19, 2026, 15:01Erik Nelson: The Biomarker that Connects Heart, Brain, and DNA
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH